To answer the question of “what’s next for breast cancer patients?” Susan G. Komen is proud to present the Breast Cancer Breakthrough Series: a virtual, shareable educational series in partnership with industry experts, scientists from academic institutions and patient advocates who will directly speak to recent clinical research findings and new treatments. This series will focus on the new science and technologies that are close to becoming available to patients.
Sign up to be reminded about the next Breast Cancer Breakthroughs episode.
Upcoming Episode
Episode 4: Unmet Needs in Triple Negative Breast Cancer
Premieres Aug. 24, 2023 at 2 p.m. EST/1 p.m. CST
Patients with metastatic triple negative breast cancer (TNBC) desperately need more therapy options. In the next episode of Breast Cancer Breakthroughs, we’ll discuss the latest news and research impacting patients with metastatic TNBC. To discuss these exciting breakthroughs, we’ll hear from Dr. Lisa Carey, a world-renowned TNBC expert and Komen Scientific Advisory Board member, and Dr. Tiffany Traina, an oncologist researching an exciting new antibody drug conjugate for TNBC.
Read a full synopsis of the episode on the Komen blog.
Find more information about the TROPION-Breast02 trial.
Latest Episode
Episode 3: Highlights from the 2023 ASCO Annual Meeting
Premiered June 29, 2023
The latest advances in breast cancer research were recently announced at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting. We’ll highlight the most exciting results from the meeting, covering topics such as CDK4/6 inhibitors, a new antibody drug conjugate and personalized medicine. Hear from experts Erika Hamilton, M.D., and Sherene Loi, M.D., Ph.D., about how these breakthroughs from ASCO will impact patient care.
Read a full synopsis of the episode on the Komen blog.
Past Episodes
Episode 2: Demystifying Treatment De-Escalation
Premiered April 25, 2023
Doctors treat breast cancer through a combination of surgery, radiation and pharmaceuticals, but are these grueling regimens necessary for all patients? Learn from experts Dr. Antonio Wolff and Dr. Daniel Stover about the latest breakthroughs in breast cancer research that are pinpointing which patients can safely avoid some treatments to effectively treat their cancer.
Read a full synopsis of the episode on the Komen Blog.
Episode 1: Highlight from the San Antonio Breast Cancer Symposium
Premiered Feb. 14, 2023
In this first installment of the Breast Cancer Breakthroughs series, Victoria Smart, Senior Vice President of Mission at Komen, joins Thelma Brown, a two-time breast cancer survivor and Komen Advocate in Science, and Dr. Sara Tolaney, Komen Scholar and oncologist, to discuss some of the exciting developments that came out of the 2022 San Antonio Breast Cancer Symposium (SABCS).
Read a full synopsis of the episode on the Komen Blog.
About Breast Cancer Breakthroughs
Advances in research, technologies and clinical trial results are being announced at a record pace, but what does it mean for patients? Patients and caregivers need to be hopeful and informed about the developing breast cancer treatments of tomorrow. This series will shine a light on the exciting new treatments and technologies that are on the horizon for patients.
Sponsors
Thank you to the following partners for their support of the Breast Cancer Breakthroughs Series

